Immunization therapy in Alzheimer's disease

被引：3

作者：

Mor, Felix ^{[1
,2
]}

Monsonego, Alon ^{[3
,4
]}

机构：

[1] Tel Aviv Univ, Weizmann Inst Sci, Dept Immunol, Rehovot, Israel

[2] Sackler Fac Med, Rabin Med Ctr, Dept Med B, Tel Aviv, Israel

[3] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel

[4] Ben Gurion Univ Negev, Dept Microbiol & Immunol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel

来源：

EXPERT REVIEW OF NEUROTHERAPEUTICS | 2006年 / 6卷 / 05期

关键词：

Alzheimer's disease; clinical trials; meningoencephalitis; Th1/Th2; balance; vaccination;

D O I：

10.1586/14737175.6.5.653

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-beta peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.

引用

页码：653 / 659

页数：7

共 69 条

[1] Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from β-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide [J].

Agadjanyan, MG ;

Ghochikyan, A ;

Petrushina, I ;

Vasilevko, V ;

Movsesyan, N ;

Mkrtichyan, M ;

Saing, T ;

Cribbs, DH .

JOURNAL OF IMMUNOLOGY, 2005, 174 (03) :1580-1586

[2] Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis [J].

Aharoni, R ;

Arnon, R ;

Eilam, R .

JOURNAL OF NEUROSCIENCE, 2005, 25 (36) :8217-8228

[3] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].

Bard, F ;

Cannon, C ;

Barbour, R ;

Burke, RL ;

Games, D ;

Grajeda, H ;

Guido, T ;

Hu, K ;

Huang, JP ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, M ;

Lieberburg, I ;

Motter, R ;

Nguyen, M ;

Soriano, F ;

Vasquez, N ;

Weiss, K ;

Welch, B ;

Seubert, P ;

Schenk, D ;

Yednock, T .

NATURE MEDICINE, 2000, 6 (08) :916-919

[4] Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology [J].

Bard, F ;

Barbour, R ;

Cannon, C ;

Carretto, R ;

Fox, M ;

Games, D ;

Guido, T ;

Hoenow, K ;

Hu, K ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, C ;

Lee, M ;

Motter, R ;

Nguyen, M ;

Reed, A ;

Schenk, D ;

Tang, P ;

Vasquez, N ;

Seubert, P ;

Yednock, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2023-2028

[5] Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD [J].

Bayer, AJ ;

Bullock, R ;

Jones, RW ;

Wilkinson, D ;

Paterson, KR ;

Jenkins, L ;

Millais, SB ;

Donoghue, S .

NEUROLOGY, 2005, 64 (01) :94-101

[6]

Burbach GJ, 2006, NEUROBIOL AGING

[7] Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells [J].

Butovsky, O ;

Ziv, Y ;

Schwartz, A ;

Landa, G ;

Talpalar, AE ;

Pluchino, S ;

Martino, G ;

Schwartz, M .

MOLECULAR AND CELLULAR NEUROSCIENCE, 2006, 31 (01) :149-160

[8] Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective [J].

Butovsky, O ;

Talpalar, AE ;

Ben-Yaakov, K ;

Schwartz, M .

MOLECULAR AND CELLULAR NEUROSCIENCE, 2005, 29 (03) :381-393

[9] Efficacy of anti-Aβ antibody isotypes used for intracerebroventricular immunization in TgCRND8 [J].

Chauhan, NB ;

Siegel, GJ .

NEUROSCIENCE LETTERS, 2005, 375 (03) :143-147

[10] Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with β-amyloid [J].

Cribbs, DH ;

Ghochikyan, A ;

Vasilevko, V ;

Tran, M ;

Petrushina, I ;

Sadzikava, N ;

Babikyan, D ;

Kesslak, P ;

Kieber-Emmons, T ;

Cotman, CW ;

Agadjanyan, MG .

INTERNATIONAL IMMUNOLOGY, 2003, 15 (04) :505-514

← 1 2 3 4 5 6 7 →